NASDAQ:MNMD

Mind Medicine (mindmed) . Subordinate Voting Shares Stock Predictions

etoro logo Buy MNMD
*Your capital is at risk
$20.69
+0 (+0%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

MNMD Prediction Chart

MNMD Predictions History

Latest community submissions for MNMD.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Dec 20, 2021 $1.78 -92.72% $1.72 X 96.51% 0
Dec 20, 2021 Bearish $1.72 V 0
Cristi Dumitru Cristi Dumitru @CristiDumitru.277045
Dec 16, 2021 $1.59 -93.58% $1.65 V 96.36% 0
JS JS Pro
Dec 16, 2021 $1.70 -93.13% $1.65 X 96.97% 0
JS JS Pro
Dec 15, 2021 $1.67 -93.25% $1.65 X 98.79% 2
JS JS Pro
Dec 13, 2021 $1.76 -93.26% $1.74 V 98.85% 2
JS JS Pro
Dec 10, 2021 $1.84 -93.26% $1.82 V 98.90% 2
JS JS Pro
Dec 9, 2021 $1.96 -93.12% $1.90 V 96.84% 1
JS JS Pro
Dec 8, 2021 $1.95 -93.53% $2.01 X 97.01% 1
JS JS Pro
Dec 7, 2021 $1.77 -93.79% $1.90 X 93.16% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MNMD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT MIND MEDICINE (MINDMED) INC. SUBORDINATE VOTING SHARES
Mind Medicine (MindMed) . Subordinate Voting Shares
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has co...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE